Back to Search
KEITH WHITEMAN, PHARMD
PHARMD
Pharmacist
NPI: 1801301908Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RP00008847(NM)
Research & Publications (11)
Semisynthetic maytansine analogues for the targeted treatment of cancer.
PMID 16821799·J Med Chem·2006
7-preclinical
Implementing a standardized safety procedure for continuous renal replacement therapy solutions.
PMID 16595818·Am J Health Syst Pharm·2006
5-case
In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
PMID 15231675·Cancer Res·2004
7-preclinical
Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells.
PMID 15292058·Blood·2004
7-preclinical
Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating.
PMID 12062505·Int J Pharm·2002
7-preclinical
p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.
PMID 11286983·Biochim Biophys Acta·2001
7-preclinical
Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification.
PMID 11575478·Biomaterials·2001
7-preclinical
Poly(Hpma)-coated liposomes demonstrate prolonged circulation in mice.
PMID 19530930·J Liposome Res·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1870 E HISTORIC HIGHWAY 66
GALLUP, NM 87301 - Phone
- (505) 722-9499
Quick Facts
- NPI
- 1801301908
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 11
Are you this provider?
Claim Your Profile